Crystalline Forms Of (6R) -L-Erythro-Tetrahydrobiopterin Dihydrochloride

Patent No. EP1687308 (titled "Crystalline Forms Of (6R) -L-Erythro-Tetrahydrobiopterin Dihydrochloride") was filed by Merck & CIE on Nov 17, 2004. The application was issued on Jun 12, 2019.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
LEDERER & KELLERMar 11, 2020KALHAMMER
LEDERER & KELLERMar 11, 2020LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP1687308

MERCK & CIE
Application Number
EP04820966A
Filing Date
Nov 17, 2004
Status
Opposition Rejected
Apr 8, 2022
Publication Date
Jun 12, 2019